Modern drug delivery strategies applied to natural active compounds

Expert Opinion on Drug Delivery

Volumn 14, Issue 6, 2017, Pages 755-768

  Puglia, Carmelo ^a   Lauro, Maria Rosaria ^b   Tirendi, Giorgia Giusy ^c   Fassari, Giuseppina Emanuela ^c   Carbone, Claudia ^a   Bonina, Francesco ^a   Puglisi, Giovanni ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c Azienda Ospedaliera di Rilievo Nazionale ed di Alta Specializzazione Garibaldi   (Italy)

Author keywords

micro and nanoemulsions; Phytochemicals; polymeric nanoparticles and lipid nanoparticles; vesicular carriers

Indexed keywords

GLYCYRRHETINIC ACID PHOSPHOLIPID COMPLEX; NANOPARTICLE; NATURAL PRODUCT; NIOSOME; PLANT MEDICINAL PRODUCT; POLYMER; BIOLOGICAL PRODUCT; DRUG; DRUG CARRIER;

DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; FIRST PASS EFFECT; HUMAN; MICROEMULSION; NANOEMULSION; NANOTECHNOLOGY; NONHUMAN; REVIEW; BIOAVAILABILITY; CHEMISTRY; SOLUBILITY;

BIOLOGICAL AVAILABILITY; BIOLOGICAL PRODUCTS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS; SOLUBILITY;

EID: 85019057936     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1080/17425247.2017.1234452     Document Type: Review

References (98)

1. Hoffman FA., Botanicals as “new” drugs:US development. Epilepsy Behav. 2015;52:338–343.
2. Benowitz S. As war on cancer hits 25-year mark, scientists see progress, challenges. Scientist. 1996;10:1−7.
3. Danishefsky S. On the potential of natural products in the discovery of pharma leads:a case for reassessment. Nat Prod Rep. 2010;27:1114−16.
4. Rates SMK. Plants as source of drugs. Toxicon. 2001;39:603–613.
5. Lauro MR, Maggi L, Conte U, et al. Rutin and quercetin gastro-resistant microparticles obtained by spray-drying technique. J Drug Deliv Sci Technol. 2005;15:363–369.
6. Lauro MR, De Simone F, Sansone F, et al. Preparations and release characteristics of naringin and naringenin gastro-resistant microparticles by spray-drying. J Drug Deliv Sci Technol. 2007;17:119–124.
7. Sansone F, Rossi A, Del Gaudio P, et al. Hesperidin gastroresistant microparticles by spray-drying:preparation, characterization, and dissolution profiles. AAPS PharmSciTech. 2009;10:391–401.
8. Sansone F, Picerno P, Mencherini T, et al. Flavonoid microparticles by spray-drying:influence of enhancers of the dissolution rate on properties and stability. J Food Eng. 2011;103:188–196.
9. Sansone F, Mencherini T, Picerno P, et al. Maltodextrin/pectin microparticles by spray drying as carrier for nutraceutical extracts. J Food Eng. 2011;105:468–476.
10. Sharma M. Applications of nanotechnology based dosage forms for delivery of herbal drugs. Rrjpnt. 2014;2:23–30.
11. Bilia AR, Isacchi B, Righeschi C, et al. Flavonoids loaded in nanocarriers:an opportunity to increase oral bioavailability and bioefficacy. Food Nutr Sci. 2014;5:1212–1227.
12. Castangia I, Nacher A, Caddeo C, et al. Therapeutic efficacy of quercetin enzyme-responsive nanovesicles for the treatment of experimental colitis in rats. Acta Biomater. 2015;13:216–227.
13. Shen LN, Zhang YT, Wang Y, et al. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. Int J Pharm. 2014;460:280–288.
14. Yeh MI, Huang HC, Liaw JH, et al. Ethosomes in hair dye products as carriers of the major compounds of black tea extracts. Int J Dermatol. 2013;52:868–875.
15. Ahmed K, Li Y, McClements DJ, et al. Nanoemulsion- and emulsion- based delivery systems for curcumin:encapsulation and release properties. Food Chem. 2012;132:799–80.
16. Aditya NP, Aditya S, Yang H, et al. Co-delivery of hydrophobic curcumin and hydrophilic catechin by a water-in-oil-in-water double emulsion. Food Chem. 2015;173:7–13.
17. Barras A, Mezzetti A, Richard A, et al. Formulation and characterization of polyphenol-loaded lipid nanocapsules. Int J Pharm. 2009;379:270–277.
18. Cui J, Yu B, Zhao Y, et al. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm. 2009;371:148–155.
19. Bergonzi MC, Hamdouch R, Mazzacuva F, et al. Optimization, characterization and in vitro evaluation of curcumin microemulsions. LWT-Food Sci Techn. 2014;59:148–155.
20. Dhumal DM, Kothari PR, Kalhapure RS, et al. Self-microemulsifying drug delivery system of curcumin with enhanced solubility and bioavailability using a new semi-synthetic bicephalous heterolipid:in vitro and in vivo evaluation. RSC Adv. 2015;5:90295–90306.
21. Chatzidaki MD, Mitsou E, Yaghmur A, et al. Formulation and characterization of food-grade microemulsions as carriers of natural phenolic antioxidants. Colloids Surf A Physicochem Eng Asp. 2015;483:130–136.
22. Fan Y, Ma L, Zhang W, et al. Microemulsion can improve the immune-enhancing activity of propolis flavonoid on immune suppression and immune response. Int J Biol Macr. 2014;65:126–132.
23. Ahmed K, Li Y, McClements DJ, et al. Nanoemulsion- and emulsion- based delivery systems for curcumin:encapsulation and release properties. Food Chem. 2012;132:799–807.
24. Sari TP, Mann B, Kumar R, et al. Preparation and characterization of nanoemulsion encapsulating curcumin. Food Hyd. 2015;43:540–546.
25. Borrin TR, Georges EL, Moraes ICF, et al. Curcumin-loaded nanoemulsions produced by the emulsion inversion point (EIP) method:an evaluation of process parameters and physicochemical stability. J Food Eng. 2016;169:1–9.
26. Pinheiro AC, Coimbra MA, Vicente AA. In vitro behaviour of curcumin nanoemulsions stabilized by biopolymer emulsifiers- effect of interfacial composition. Food Hyd. 2016;52:460–467.
27. Thangapazham RL, Puri A, Tele S, et al. Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int J Oncol. 2008;32:1119–1123.
28. Shi HS, Gao X, Dan L, et al. A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation. Int J Nanomed. 2012;7:2601–2611.
29. Catania A, Barrajon-Catalan E, Nicolosi S, et al. Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells. Breast Cancer Res Treat. 2013;141:55–65.
30. El-Refaie WM, Elnaggar YSR, El-Massik MA, et al. Novel curcumin-loaded gel-core hyaluosomes with promising burn-wound healing potential:development, in-vitro appraisal and in-vivo studies. Int J Pharm. 2015;486:88–98.
31. Leto I, Coronnello M, Righeschi C, et al. Enhanced efficacy of artemisinin loaded in transferrin-conjugated liposomes versus stealth liposomes against HCT-8 colon cancer cells. ChemMedChem. 2016;11:1745–1751. DOI:10.1002/cmdc.201500586
32. Isacchi B, Arrigucci S, la Marca G, et al. Conventional and long-circulating liposomes of artemisinin:preparation, characterization, and pharmacokinetic profile in mice. J Liposome Res. 2011;21:237–244.
33. Celia C, Trapasso E, Locatelli M, et al. Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells. Colloids Surf B. 2013;112:548–553.
34. Wang X, Cai L, Zhang X, et al. Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol. Int J Pharm. 2011;410:169–174.
35. Mignet N, Seguin J, Ramos Romano M, et al. Development of a liposomal formulation of the natural flavonoid fisetin. Int J Pharm. 2012;423:69–76.
36. Seguin J, Brulle L, Boyer R, et al. Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy. Int J Pharm. 2013;444:146–154.
37. Lin YL, Chang KF, Huang XF, et al. Liposomal n-butylidenephthalide protects the drug from oxidation and enhances its antitumor effects in glioblastoma multiforme. Int J Nanomed. 2015;10:6009–6020.
38. Wang G, Wang JJ, To TS, et al. Role of SIRT1-mediated mitochondrial and Akt pathways in glioblastoma cell death induced by cotinus coggygria flavonoid nanoliposomes. Int J Nanomed. 2015;10:5005–5023.
39. Mohan A, Narayanan S, Balasubramanian G, et al. Dual drug loaded nanoliposomal chemotherapy:a promising strategy for treatment of head and neck squamous cell carcinoma. Eur J Pharm Biopharm. 2016;99:73–83.
40. Campani V, Biondi M, Mayol L, et al. Nanocarriers to enhance the accumulation of vitamin K1 into the skin. Pharm Res. 2016;33:893–908.
41. Isacchi B, Fabbri V, Galeotti N, et al. Salvianolic acid B and its liposomal formulations:anti-hyperalgesic activity in the treatment of neuropathic pain. Eur J Pharm Sci. 2011;44:552–558.
42. Sinico C, Caddeo C, Valenti D, et al. Liposomes as carriers for verbascoside:stability and skin permeation studies. J Liposome Res. 2008;18:83–90.
43. Caddeo C, Chessa M, Vassallo A, et al. Extraction, purification and nanoformulation of natural phycocyanin (from Klamath algae) for dermal and deeper soft tissue delivery. J Biomed Nanotechnol. 2013;9:1929–1938.
44. Kwon SS, Kim SY, Kong BJ, et al. Cell penetrating peptide conjugated liposomes as transdermal delivery system of polygonum aviculare L. extract. Extract. Int J Pharm. 2015;483:26–37.
45. Caddeo C, Díez-Sales O, Pons R, et al. Topical anti-inflammatory potential of quercetin in lipid-based nanosystems:in vivo and in vitro evaluation. Pharm Res. 2014;31:959–968.
46. Kang MJ, Eum JY, Park SH, et al. Pep-1 peptide-conjugated elastic liposomal formulation of taxifolin glycoside for the treatment of atopic dermatitis in NC/Nga mice. Int J Pharm. 2010;402:198–204.
47. Gonzalez-Paredes A, Clares-Naveros B, Ruiz-Martinez M, et al. Delivery systems for natural antioxidant compounds:archaeosomes and archaeosomal hydrogels characterization and release study. Int J Pharm. 2011;421:321–331.• An interesting paper introducing archaeosomes.
48. Paolino D, Cosco D, Cilurzo F, et al. Improved in vitro and in vivo collagen biosynthesis by asiaticoside-loaded ultradeformable vesicles. J Control Release. 2012;162:143–151.
49. Zhang J, Han X, Li X, et al. Core-shell hybrid liposomal vesicles loaded with panax notoginsenoside:preparation, characterization and protective effects on global cerebral ischemia/reperfusion injury and acute myocardial ischemia in rats. Int J Nanomed. 2012;7:4299–4310.
50. Zheng B, Yang S, Fan C, et al. Oleic acid derivative of polyethylenimine-functionalized proliposomes for enhancing oral bioavailability of extract of Ginkgo biloba. Drug Deliv. 2015;3:1–10.
51. Scognamiglio I, De Stefano D, Campani V, et al. Nanocarriers for topical administration of resveratrol:a comparative study. Int J Pharm. 2013;440:179–187.
52. Ascenso A, Pinho S, Eleuterio C, et al. Lycopene from tomatoes:vesicular nanocarrier formulations for dermal delivery. J Agric Food Chem. 2013;61:7284–7293.
53. Sarwa KK, Das PJ, Mazumder B. A nanovesicle topical formulation of Bhut Jolokia (hottest capsicum):a potential anti-arthritic medicine. Expert Opin Drug Deliv. 2014;11:661–676.
54. Paolino D, Muzzalupo R, Ricciardi A, et al. In vitro and in vivo evaluation of bola-surfactant containing niosomes for transdermal delivery. Biomed Microdevices. 2007;9:421–433.
55. Marianecci C, Rinaldi F, Mastriota M, et al. Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system:human and murine models. J Control Release. 2012;164:17–25.• A well-conducted study to evaluate the efficacy of niosomes in dermal drug delivery.
56. Junyaprasert VB, Singhsa P, Suksiriworapong J, et al. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. Int J Pharm. 2012;423:303–311.
57. Manosroi A, Ruksiriwanich W, Abe M, et al. Transfollicular enhancement of gel containing cationic niosomes loaded with unsaturated fatty acids in rice (Oryza sativa) bran semi-purified fraction. Eur J Pharm Biopharm. 2012;81:303–313.
58. Jin Y, Wen J, Garg S, et al. Development of a novel niosomal system for oral delivery of Ginkgo biloba extract. Int J Nanomed. 2013;8:421–430.
59. Kamble B, Talreja S, Gupta A, et al. Development and biological evaluation of Gymnema sylvestre extract-loaded nonionic surfactant-based niosomes. Nanomedicine. 2013;8:1295–1305.
60. Zhang J, Tang Q, Xu X, et al. Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery. Int J Pharm. 2013;448:168–174.
61. Angelico R, Ceglie A, Sacco P, et al. Phyto-liposomes as nanoshuttles for water-insoluble silybin-phospholipid complex. Int J Pharm. 2014;471:173–181.
62. Scarfato P, Avallone E, Iannelli P, et al. Quercetin microspheres by solvent evaporation:preparation, characterization and release behavior. J App Polym Sci. 2008;109:2994–3001.
63. Sansone F, Picerno P, Mencherini T, et al. Enhanced technological and permeation properties of a microencapsulated soy isoflavones extract. J Food Eng. 2013;115:298–305.
64. Shu B, Yu W, Zhao Y, et al. Study on microencapsulation of lycopene by spray-drying. J Food Eng. 2006;76:664–669.
65. Sanna V, Roggio AM, Pala N, et al. Effect of chitosan concentration on PLGA microcapsules for controlled release and stability of resveratrol. Int J Biol Macro. 2015;72:531–536.
66. Xiao B, Si X, Zhang M, et al. Oral administration of pH-sensitive curcumin-loaded microparticlesfor ulcerative colitis therapy. Colloids Surf B. 2015;135:379–385.
67. Patel AR, Seijen-ten-Hoorn J, Velikov KP. Colloidal complexes from associated water-soluble cellulose derivative (methylcellulose) and green tea polyphenol (Epigallocatechin gallate). J Colloid Int Sci. 2011;364:317–323.
68. Liang J, Li F, Fang Y, et al. Synthesis, characterization and cytotoxicity studies of chitosan-coated tea polyphenols nanoparticles. Colloids Surf B. 2011;82:297–301.
69. Musazzi UM, Youm I, Murowchick JB, et al. Resveratrol-loaded nanocarriers:formulation, optimization, characterization and in vitro toxicity on cochlear cells. Colloids Surf B. 2014;118:234–242.
70. Tsai YM, Jan WC, Chien CF, et al. Optimized nano-formulation on the bioavailability of hydrophobic polyphenol, curcumin, in freely-moving rats. Food Chem. 2011;127:918–925.
71. Hazzah HA, Farid RM, Nasra MMA, et al. Gelucire-based nanoparticles for curcumin targeting to oral mucosa:preparation, characterization, and antimicrobial activity assessment. J Pharm Sci. 2015;104:3913–3924.
72. Gaur PK, Mishra S, Verma A, et al. Ceramide-palmitic acid complex based Curcumin solid lipid nanoparticles for transdermal delivery:pharmacokinetic and pharmacodynamic study. J Exp Nanosci. 2016;11:38–53.
73. Arora R, Kuhad A, Kaur IP, et al. Curcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in rats. Eur J Pain. 2015;19:940–952.• A major study demonstrates the effectiveness of the phytochemicals encapsulation in lipid nanoparticles.
74. Wang J, Wang H, Zhu R, et al. Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis. Biomaterials. 2015;53:475–483.
75. Singh N, Khullar N, Kakkar V, et al. Attenuation of carbon tetrachloride-induced hepatic injury with curcumin-loaded solid lipid nanoparticles. Biodrugs. 2014;28:297–312.
76. Puglia C, Frasca G, Musumeci T, et al. Curcumin loaded NLC induces histone hypoacetylation in the CNS after intraperitoneal administration in mice. Eur J Pharm Biopharm. 2012;81:288–293.
77. Cengiz M, Kutlu HM, Burukoglu DD, et al. A comparative study on the therapeutic effects of silymarin and silymarin-loaded solid lipid nanoparticles on DGaIN/TNF-α-induced liver damage in Balb/c mice. Food Chem Toxicol. 2015;77:93–100.
78. Singh N, Khullar N, Kakkar V, et al. Sesamol loaded solid lipid nanoparticles:a promising intervention for control of carbon tetrachloride induced hepatotoxicity. BMC Complem Altern M. 2015;15:1–26.
79. Puglia C, Lauro MR, Offerta A, et al. Nanostructured Lipid Carriers (NLC) as vehicles for topical administration of sesamol:in vitro percutaneous absorption study and evaluation of antioxidant activity. Planta Med. 2016. DOI:10.1055/s-0042-105293
80. Ban C, Park SJ, Lim S, et al. Improving flavonoid bioaccessibility using an edible oil-based lipid nanoparticle for oral delivery. J Agr Food Chem. 2015;63:5266–5272.
81. Campos DA, Madureira AR, Gomes AM, et al. Optimization of the production of solid Witepsol nanoparticles loaded with rosmarinic acid. Colloids Surf B. 2014;115:109–117.
82. Okonogi S, Riangjanapatee P. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration. Int J Pharm. 2015;478:726–735.
83. Tronino D, Offerta A, Ostacolo C, et al. Nanoparticles prolong N-palmitoylethanolamide anti-inflammatory and analgesic effects in vivo. Colloids Surf B. 2016;141:311–317.
84. El-Abbassi A, Neves MA, Kobayashi I, et al. Preparation and characterization of highly stable monodisperse argan oil-in-water emulsions using microchannel emulsification. Eur J Lipid Sci Technol. 2013;115:224–231.
85. Neves A, Hashemi J, Prentice C. Development of novel bioactives delivery systems by micro/nanotechnology. Curr Op Food Sci. 2015;1:7–12.
86. Sudheer P, Kar K, Saha C. Microemulsion NDDS:microemulsion a versatile dimension of novel drug delivery system. J Pharm Sci. 2015;5:21–31.
87. Paolino D, Cosco D, Cilurzo F, et al. Innovative drug delivery systems for the administration of natural compounds. Curr Bioact Compd. 2007;16:262–277.
88. Puglia C, Tirendi GG, Bonina F. Emerging role of colloidal drug delivery systems (CDDS) in NSAID topical administration. Curr Med Chem. 2013;20:1847–1857.
89. Pradhan M, Singh D, Singh MR. Novel colloidal carriers for psoriasis:current issues, mechanistic insight and novel delivery approaches. J Control Release. 2013;170:380–395.
90. Chakravarthi SS, Robinson DH, De S. Nanoparticles prepared using natural and synthetic polymers. In:Deepak Thassu, Michel Deleers, Yashwant Pathak, editors. Nanoparticulate drug delivery systems. New York (NY):Informa healthcare; 2007.
91. Puglia C, Bonina F. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin Drug Deliv. 2012;9:429–441.
92. Maheshwari RK, Ak S, Gaddipati J, et al. Multiple biological activities of curcumin:a short review. Life Sci. 2006;78:2081–2087.
93. Shaikh J, Ankola DD, Beniwal V, et al. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci. 2009;37:223–230.
94. Coimbra M, Crielaard BJ, Storm G, et al. Critical factors in the development of tumor-targeted anti-inflammatory nanomedicines. J Control Release. 2012;160:232–238.
95. Gupta SC, Kim JH, Prasad S, et al. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 2010;29:405–434.
96. Marianecci C, Di Marzio L, Rinaldi F, et al. Niosomes from 80s to present:the state of the art. Adv Colloid Interface Sci. 2014;205:187–206.
97. Hu M. Commentary:bioavailability of flavonoids and polyphenols:call to arms. Mol Pharm. 2007;4:803–806.
98. Müller RH, Shegokar R, Keck CM. 20 years of lipid nanoparticles (SLN and NLC):present state of development and industrial applications. Curr Drug Discov Technol. 2011;8:207–227.